Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to 0.21%.

  • Burning Rock Biotech's Return on Capital Employed rose 3800.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year increase of 3800.0%. This contributed to the annual value of 0.5% for FY2024, which is 1200.0% up from last year.
  • Burning Rock Biotech's Return on Capital Employed amounted to 0.21% in Q3 2025, which was up 3800.0% from 0.24% recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Return on Capital Employed high stood at 0.19% for Q4 2021, and its period low was 0.82% during Q4 2022.
  • In the last 5 years, Burning Rock Biotech's Return on Capital Employed had a median value of 0.59% in 2022 and averaged 0.51%.
  • As far as peak fluctuations go, Burning Rock Biotech's Return on Capital Employed tumbled by -10100bps in 2022, and later surged by 5400bps in 2025.
  • Over the past 5 years, Burning Rock Biotech's Return on Capital Employed (Quarter) stood at 0.19% in 2021, then tumbled by -538bps to 0.82% in 2022, then rose by 1bps to 0.81% in 2023, then skyrocketed by 35bps to 0.52% in 2024, then soared by 60bps to 0.21% in 2025.
  • Its last three reported values are 0.21% in Q3 2025, 0.24% for Q2 2025, and 0.4% during Q1 2025.